D-0524-2026 Class II Ongoing

Recalled by Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles — Santa Fe Springs, CA

FDA drug recall D-0524-2026 was initiated by Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles on Dec 27, 2025 and is designated Class II. Reason for recall: Incorrect Product Formulation: product did not contain insulin as listed in the label. The recall status is ongoing. Affected quantity: 1 bag.

Recall details

Product Type
Drugs
Report Date
May 13, 2026
Initiation Date
Dec 27, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 bag

Product description

TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670

Reason for recall

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Distribution pattern

CA

Code information

Lot #: 11-4909703-0-1, Exp 12/28/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0524-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0524-2026. Report a data issue: hello@regdatalab.com.